FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2126822957> ?p ?o ?g. }

• W2126822957 endingPage "306" @default.
• W2126822957 startingPage "294" @default.
• W2126822957 abstract "<h2>Abstract</h2> <b>Background:</b> Lowering low-density lipoprotein cholesterol (LDL-C) is the primary focus of the management of dyslipidemia in patients with or at risk for cardiovascular disease. However, use of a statin alone may be insufficient for the treatment of mixed dyslipidemia, which is characterized by low levels of high-density lipoprotein cholesterol and elevated levels of triglycerides, with or without elevated levels of LDL-C. <b>Objective:</b> This report reviews the evidence for the efficacy and tolerability of different combination treatments for the management of mixed dyslipidemia, as supported by clinical-trial data and recommended by national guidelines. <b>Methods:</b> Using the terms <i>lipid-modifying therapy, combination therapy, combination statin-fibrate therapy</i>, and <i>mixed dyslipidemia</i>, a search of PubMed was conducted (completed in April 2007, updated to October 2007) to identify English-language publications and pertinent studies of fibrate combination therapy in patients with mixed dyslipidemia, including those with diabetes or the metabolic syndrome. <b>Results:</b> National guidelines recommend the addition of either niacin (nicotinic acid) or a fibrate to statin therapy in patients with mixed dyslipidemia to achieve better overall lipid control. Fibrates do not have detrimental effects on uric acid levels or glycemic control in patients with diabetes or the metabolic syndrome. Based on data from the US Food and Drug Administration Adverse Event Reporting System indicating that gemfibrozil plus a statin was associated with a 15-fold higher risk of rhabdomyolysis than fenofibrate plus a statin, fenofibrate may be the fi-brate of choice for use in combination with a statin. As reported by the Fenofibrate Intervention and Event Lowering in Diabetes study, fenofibrate treatment has also been associated with microvascular benefits in patients with type 2 diabetes, which is consistent with preliminary evidence from the Diabetes Atherosclerosis Intervention Study. <b>Conclusion</b>: The addition of fenofibrate to statin therapy may be a useful strategy for the management of mixed dyslipidemia in patients with or at risk for cardiovascular disease." @default.
• W2126822957 created "2016-06-24" @default.
• W2126822957 creator A5067797353 @default.
• W2126822957 date "2008-02-01" @default.
• W2126822957 modified "2023-09-24" @default.
• W2126822957 title "Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: A role for combination fibrate therapy" @default.
• W2126822957 cites W1502524639 @default.
• W2126822957 cites W1566044237 @default.
• W2126822957 cites W1971175832 @default.
• W2126822957 cites W1976428272 @default.
• W2126822957 cites W1979293590 @default.
• W2126822957 cites W1980779395 @default.
• W2126822957 cites W1982412102 @default.
• W2126822957 cites W1982444046 @default.
• W2126822957 cites W1984684948 @default.
• W2126822957 cites W1988048988 @default.
• W2126822957 cites W1990166147 @default.
• W2126822957 cites W1991088942 @default.
• W2126822957 cites W1998336053 @default.
• W2126822957 cites W2026628186 @default.
• W2126822957 cites W2028211844 @default.
• W2126822957 cites W2029471511 @default.
• W2126822957 cites W2034600674 @default.
• W2126822957 cites W2040433877 @default.
• W2126822957 cites W2046285201 @default.
• W2126822957 cites W2053536280 @default.
• W2126822957 cites W2054042843 @default.
• W2126822957 cites W2055974197 @default.
• W2126822957 cites W2058019883 @default.
• W2126822957 cites W2059863792 @default.
• W2126822957 cites W2072532932 @default.
• W2126822957 cites W2077760013 @default.
• W2126822957 cites W2078807483 @default.
• W2126822957 cites W2079872539 @default.
• W2126822957 cites W2086602774 @default.
• W2126822957 cites W2094768566 @default.
• W2126822957 cites W2100800328 @default.
• W2126822957 cites W2101333957 @default.
• W2126822957 cites W2101393751 @default.
• W2126822957 cites W2102906564 @default.
• W2126822957 cites W2102941237 @default.
• W2126822957 cites W2106340207 @default.
• W2126822957 cites W2106343349 @default.
• W2126822957 cites W2107295258 @default.
• W2126822957 cites W2114027342 @default.
• W2126822957 cites W2115728877 @default.
• W2126822957 cites W2116623091 @default.
• W2126822957 cites W2119634418 @default.
• W2126822957 cites W2121209370 @default.
• W2126822957 cites W2123002906 @default.
• W2126822957 cites W2125692663 @default.
• W2126822957 cites W2128408811 @default.
• W2126822957 cites W2132317196 @default.
• W2126822957 cites W2137489898 @default.
• W2126822957 cites W2139168645 @default.
• W2126822957 cites W2143893927 @default.
• W2126822957 cites W2147176408 @default.
• W2126822957 cites W2154704322 @default.
• W2126822957 cites W2159449551 @default.
• W2126822957 cites W2160390128 @default.
• W2126822957 cites W2161474086 @default.
• W2126822957 cites W2167067204 @default.
• W2126822957 cites W2171569022 @default.
• W2126822957 cites W2198678228 @default.
• W2126822957 cites W2247997571 @default.
• W2126822957 cites W2328529137 @default.
• W2126822957 cites W2400712338 @default.
• W2126822957 cites W4230870013 @default.
• W2126822957 cites W4232689095 @default.
• W2126822957 cites W4237787323 @default.
• W2126822957 cites W1521959273 @default.
• W2126822957 doi "https://doi.org/10.1016/j.clinthera.2008.02.004" @default.
• W2126822957 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18343268" @default.
• W2126822957 hasPublicationYear "2008" @default.
• W2126822957 type Work @default.
• W2126822957 sameAs 2126822957 @default.
• W2126822957 citedByCount "27" @default.
• W2126822957 countsByYear W21268229572012 @default.
• W2126822957 countsByYear W21268229572013 @default.
• W2126822957 countsByYear W21268229572014 @default.
• W2126822957 countsByYear W21268229572015 @default.
• W2126822957 countsByYear W21268229572016 @default.
• W2126822957 countsByYear W21268229572017 @default.
• W2126822957 countsByYear W21268229572018 @default.
• W2126822957 countsByYear W21268229572022 @default.
• W2126822957 crossrefType "journal-article" @default.
• W2126822957 hasAuthorship W2126822957A5067797353 @default.
• W2126822957 hasConcept C126322002 @default.
• W2126822957 hasConcept C134018914 @default.
• W2126822957 hasConcept C2776839432 @default.
• W2126822957 hasConcept C2776933373 @default.
• W2126822957 hasConcept C2776999253 @default.
• W2126822957 hasConcept C2778096610 @default.
• W2126822957 hasConcept C2778110834 @default.
• W2126822957 hasConcept C2778163477 @default.
• W2126822957 hasConcept C2778670441 @default.
• W2126822957 hasConcept C2779134260 @default.
• W2126822957 hasConcept C2780092750 @default.

• next